Literature DB >> 33364946

Phytocannabinoids Profile in Medicinal Cannabis Oils: The Impact of Plant Varieties and Preparation Methods.

Michele Dei Cas1, Eleonora Casagni2, Antonella Casiraghi2, Paola Minghetti2, Diego Maria Michele Fornasari3, Francesca Ferri2, Sebastiano Arnoldi2, Veniero Gambaro2, Gabriella Roda2.   

Abstract

Cannabis (Cannabis sativa L.) is a highly promising medicinal plant with well-documented effectiveness and growing use in the treatment of various medical conditions. Cannabis oils are mostly used in galenic preparations, due to their easy adjustment of the administration dose, together with the enhanced bioavailability of its active compounds. As stated by the Italian Law (9/11/2015, 279 Official Gazette), "to ensure the quality of the oil-based cannabis preparation, the titration of the active substance(s) should be carried out." This study aims to represent the Italian panorama of cannabis oils, which were analyzed (8,201) to determine their cannabinoids content from 2017 to 2019. After application of the exclusion criteria, 4,774 standardized cannabis oils were included, which belong to different medicinal cannabis varieties and prepared according to different extraction methods. The concentration of the principal cannabinoids was taken into account dividing samples on the basis of the main extraction procedures and cannabis varieties. According to this analysis, the most substantial variations should be attributed to different cannabis varieties rather than to their extraction protocols. This study may be the starting point of preparatory pharmacists to assess the correct implementation of the preparation procedures and the quality of the extracts.
Copyright © 2020 Dei Cas, Casagni, Casiraghi, Minghetti, Fornasari, Ferri, Arnoldi, Gambaro and Roda.

Entities:  

Keywords:  cannabinoids; chemometrics methods; medical cannabis; pharmaceutical chemistry; phytochemistry

Year:  2020        PMID: 33364946      PMCID: PMC7751640          DOI: 10.3389/fphar.2020.570616

Source DB:  PubMed          Journal:  Front Pharmacol        ISSN: 1663-9812            Impact factor:   5.810


  35 in total

Review 1.  Pharmacology of cannabinoids in the treatment of epilepsy.

Authors:  Tyler E Gaston; Daniel Friedman
Journal:  Epilepsy Behav       Date:  2017-01-10       Impact factor: 2.937

Review 2.  The Role of Cannabidiol (CBD) in Chronic Pain Management: An Assessment of Current Evidence.

Authors:  Shafik Boyaji; Justin Merkow; R Noel M Elman; Alan D Kaye; R Jason Yong; Richard D Urman
Journal:  Curr Pain Headache Rep       Date:  2020-01-24

Review 3.  Practical considerations in medical cannabis administration and dosing.

Authors:  Caroline A MacCallum; Ethan B Russo
Journal:  Eur J Intern Med       Date:  2018-01-04       Impact factor: 4.487

4.  Determination of Cannabinoids in Cannabis sativa Dried Flowers and Oils by LC-UV: Single-Laboratory Validation, First Action 2018.10.

Authors:  Elizabeth M Mudge; Paula N Brown
Journal:  J AOAC Int       Date:  2020-04-01       Impact factor: 1.913

5.  Identification of 1-butyl-3-(1-(4-methyl)naphtoyl)indole detected for the first time in "herbal high" products on the Italian market.

Authors:  Ermanno Valoti; Eleonora Casagni; Lucia Dell'Acqua; Marco Pallavicini; Gabriella Roda; Chiara Rusconi; Valentina Straniero; Veniero Gambaro
Journal:  Forensic Sci Int       Date:  2012-08-29       Impact factor: 2.395

6.  Evaluation of cannabinoids concentration and stability in standardized preparations of cannabis tea and cannabis oil by ultra-high performance liquid chromatography tandem mass spectrometry.

Authors:  Roberta Pacifici; Emilia Marchei; Francesco Salvatore; Luca Guandalini; Francesco Paolo Busardò; Simona Pichini
Journal:  Clin Chem Lab Med       Date:  2017-08-28       Impact factor: 3.694

Review 7.  Cannabinoids for treatment of glaucoma.

Authors:  Gary D Novack
Journal:  Curr Opin Ophthalmol       Date:  2016-03       Impact factor: 3.761

8.  Behavioural and pharmacological characterization of a novel cannabinomimetic adamantane-derived indole, APICA, and considerations on the possible misuse as a psychotropic spice abuse, in C57bl/6J mice.

Authors:  Carla Cannizzaro; Ginevra Malta; Antonina Argo; Anna Brancato; Gabriella Roda; Eleonora Casagni; Laura Fumagalli; Ermanno Valoti; Rino Froldi; Paolo Procaccianti; Veniero Gambaro
Journal:  Forensic Sci Int       Date:  2016-01-06       Impact factor: 2.395

9.  Enhanced brain disposition and effects of Δ9-tetrahydrocannabinol in P-glycoprotein and breast cancer resistance protein knockout mice.

Authors:  Adena S Spiro; Alexander Wong; Aurélie A Boucher; Jonathon C Arnold
Journal:  PLoS One       Date:  2012-04-20       Impact factor: 3.240

10.  Galenic Preparations of Therapeutic Cannabis sativa Differ in Cannabinoids Concentration: A Quantitative Analysis of Variability and Possible Clinical Implications.

Authors:  Alessandra Bettiol; Niccolò Lombardi; Giada Crescioli; Valentina Maggini; Eugenia Gallo; Alessandro Mugelli; Fabio Firenzuoli; Roberto Baronti; Alfredo Vannacci
Journal:  Front Pharmacol       Date:  2019-01-17       Impact factor: 5.810

View more
  4 in total

Review 1.  Cannabinoid Formulations and Delivery Systems: Current and Future Options to Treat Pain.

Authors:  Barbara Stella; Francesca Baratta; Carlo Della Pepa; Silvia Arpicco; Daniela Gastaldi; Franco Dosio
Journal:  Drugs       Date:  2021-09-04       Impact factor: 9.546

2.  Marijuana toxicosis in 2 donkeys.

Authors:  Alyson H Fitzgerald; Geraldine Magnin; Ellen Pace; Karyn Bischoff; Toby Pinn-Woodcock; Ron Vin; Michael Myhre; Emily Comstock; Steve Ensley; Johann F Coetzee
Journal:  J Vet Diagn Invest       Date:  2022-01-17       Impact factor: 1.569

Review 3.  Phytocannabinoids Biosynthesis in Angiosperms, Fungi, and Liverworts and Their Versatile Role.

Authors:  Yamshi Arif; Priyanka Singh; Andrzej Bajguz; Shamsul Hayat
Journal:  Plants (Basel)       Date:  2021-06-28

4.  Cannabis-Based Oral Emulsion for Medical Purposes to Meet the Needs of Patients: Formulation, Quality and Stability.

Authors:  Francesca Baratta; Elena Peira; Carola Maza; Marina Gallarate; Paola Brusa
Journal:  Pharmaceutics       Date:  2022-02-25       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.